- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
ErbB2 receptor tyrosine kinase 2 (ERBB2), also known as HER2, is a transmembrane receptor localized primarily to the cell surface of epithelial and tumor cells, where it plays a central role in regulating cell signaling and growth. HER2 Antibody / Cell Surface Receptor Antibody (clone HRB2/451) targets this protein, enabling detection of membrane-associated HER2 expression in cellular and tissue contexts. HER2 antibody, also referred to as ErbB2 antibody and ERBB2 antibody in the literature, recognizes a key receptor involved in oncogenic signaling and cellular communication. This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
HER2 is a member of the epidermal growth factor receptor family and functions through dimerization with other receptor family members, activating downstream signaling pathways such as PI3K/AKT and MAPK. These pathways regulate cell proliferation, survival, and differentiation, making HER2 a critical regulator of epithelial cell biology. Unlike other EGFR family members, HER2 does not require direct ligand binding and instead acts as a preferred dimerization partner, amplifying signaling intensity and duration.
The cell surface localization of HER2 is particularly important for studies involving receptor accessibility, membrane distribution, and signaling dynamics. In immunofluorescence and flow cytometry applications, HER2 is detected as a membrane-associated protein outlining cell borders, allowing for assessment of receptor density and heterogeneity across cell populations. These approaches are widely used to evaluate HER2 expression in cancer models and to investigate receptor trafficking and internalization.
HER2 expression is frequently elevated in cancers such as breast, gastric, and ovarian carcinoma, where increased receptor density at the cell surface contributes to enhanced signaling and tumor progression. In these contexts, HER2 serves as both a biomarker and a functional driver of disease. Detection of HER2 at the plasma membrane provides insight into receptor activation states and interactions with therapeutic agents targeting extracellular domains.
Structurally, HER2 consists of a large extracellular domain, a single transmembrane region, and an intracellular tyrosine kinase domain responsible for initiating signaling cascades. Following activation, HER2 may undergo internalization and recycling, contributing to dynamic regulation of receptor availability at the cell surface. This trafficking behavior is an important consideration in studies examining receptor turnover and signaling persistence.
Protein microarray validation supports specific detection of HER2 by this antibody, while IF and FACS data highlight its utility in cell surface receptor analysis across experimental systems.
For broad detection of HER2 (ErbB2) as a receptor tyrosine kinase, see our HER2 antibody.
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the HER2 Antibody / Cell Surface Receptor Antibody to be titered up or down for optimal performance.
Recombinant human protein was used as the immunogen for this HER2 antibody.
Store the HER2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
HER2 antibody, ErbB2 antibody, HER2 membrane antibody, ERBB2 surface antibody, HER2 IF antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.